Although the ROC analysis demonstrated a statistically significant difference in serum IL-27 levels between patients with TAO and controls, the AUC (0.7–0.8) suggests only modest diagnostic accuracy, which limits the clinical utility of IL-27 as a standalone biomarker. The gene discussed is IL27; the disease is thromboangiitis obliterans.